La transplantation intestinale

Translated title of the contribution: Small intestinal transplantation

Olivier Goulet, Dominique M. Jan, Nicole Brousse, Danielle Canioni, Sabine Sarnacki, Claude Ricour, Yann Révillon

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The management of patients with intestinal failure has benefited from progress in parenteral nutrition (PN), especially home-based PN. Intestinal transplantation is henceforth possible and appears now, under certain conditions, the logical therapeutic option. Since 1985, more than 180 small-bowel grafts have been performed, involving the isolated small bowel with or without the colon (38%), the liver plus the small bowel (46%) or several more organs (16%). Two thirds of the recipients were under 20 years of age, and indications were short-bowel syndrome (64%), severe intractable diarrhea (13%), abdominal cancer (13%) or chronic intestinal pseudo-obstruction syndrome (8%). Fifty one per cent of the patients survived more than two years after graft. Patient and graft survival depend on the type of immunosuppression, i.e. CyA or FK506. The results must be carefully interpreted as they represent the first experience in numerous centers using different immunosuppression protocols, without any randomization. Results obtained in the largest of these centers are more indicative of the current situation. This article reviews the main aspects of human intestinal transplantation with special focus on graft rejection in terms of immunohistochemical expression which is decisive for diagnosis and specific treatment. Functional grafts lead to gastrointestinal autonomy (weaning of PN) while maintaining satisfactory nutritional status and normal growth in childhood. Intestinal transplantation is theoretically indicated for all patients permanently or lengthily dependent on PN. However, as PN is generally well tolerated, even for long periods, each indication of transplantation must be carefully weighed up in terms of iatrogenic risk and quality of life. When PN has reached its limits, especially those associated with vascular, infectious, hepatic or metabolic complications, intestinal transplantation must be considered. Transplantation of the small bowel alone remains the first option, as combined liver-small bowel grafting is indicated only in case of life-threatening progressive cirrhogenic liver disease.

Original languageFrench
Pages (from-to)323-334
Number of pages12
JournalMedecine/Sciences
Volume13
Issue number3
StatePublished - Mar 1997
Externally publishedYes

Fingerprint

Nutrition
Parenteral Nutrition
Grafts
Transplantation
Liver
Transplants
Immunosuppression
Home Parenteral Nutrition
Transplantation (surgical)
Intestinal Pseudo-Obstruction
Short Bowel Syndrome
Graft Rejection
Tacrolimus
Graft Survival
Random Allocation
Weaning
Nutritional Status
Blood Vessels
Liver Diseases
Diarrhea

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Goulet, O., Jan, D. M., Brousse, N., Canioni, D., Sarnacki, S., Ricour, C., & Révillon, Y. (1997). La transplantation intestinale. Medecine/Sciences, 13(3), 323-334.

La transplantation intestinale. / Goulet, Olivier; Jan, Dominique M.; Brousse, Nicole; Canioni, Danielle; Sarnacki, Sabine; Ricour, Claude; Révillon, Yann.

In: Medecine/Sciences, Vol. 13, No. 3, 03.1997, p. 323-334.

Research output: Contribution to journalArticle

Goulet, O, Jan, DM, Brousse, N, Canioni, D, Sarnacki, S, Ricour, C & Révillon, Y 1997, 'La transplantation intestinale', Medecine/Sciences, vol. 13, no. 3, pp. 323-334.
Goulet O, Jan DM, Brousse N, Canioni D, Sarnacki S, Ricour C et al. La transplantation intestinale. Medecine/Sciences. 1997 Mar;13(3):323-334.
Goulet, Olivier ; Jan, Dominique M. ; Brousse, Nicole ; Canioni, Danielle ; Sarnacki, Sabine ; Ricour, Claude ; Révillon, Yann. / La transplantation intestinale. In: Medecine/Sciences. 1997 ; Vol. 13, No. 3. pp. 323-334.
@article{b6a2bd11d99d404e84a28e822ffcabf1,
title = "La transplantation intestinale",
abstract = "The management of patients with intestinal failure has benefited from progress in parenteral nutrition (PN), especially home-based PN. Intestinal transplantation is henceforth possible and appears now, under certain conditions, the logical therapeutic option. Since 1985, more than 180 small-bowel grafts have been performed, involving the isolated small bowel with or without the colon (38{\%}), the liver plus the small bowel (46{\%}) or several more organs (16{\%}). Two thirds of the recipients were under 20 years of age, and indications were short-bowel syndrome (64{\%}), severe intractable diarrhea (13{\%}), abdominal cancer (13{\%}) or chronic intestinal pseudo-obstruction syndrome (8{\%}). Fifty one per cent of the patients survived more than two years after graft. Patient and graft survival depend on the type of immunosuppression, i.e. CyA or FK506. The results must be carefully interpreted as they represent the first experience in numerous centers using different immunosuppression protocols, without any randomization. Results obtained in the largest of these centers are more indicative of the current situation. This article reviews the main aspects of human intestinal transplantation with special focus on graft rejection in terms of immunohistochemical expression which is decisive for diagnosis and specific treatment. Functional grafts lead to gastrointestinal autonomy (weaning of PN) while maintaining satisfactory nutritional status and normal growth in childhood. Intestinal transplantation is theoretically indicated for all patients permanently or lengthily dependent on PN. However, as PN is generally well tolerated, even for long periods, each indication of transplantation must be carefully weighed up in terms of iatrogenic risk and quality of life. When PN has reached its limits, especially those associated with vascular, infectious, hepatic or metabolic complications, intestinal transplantation must be considered. Transplantation of the small bowel alone remains the first option, as combined liver-small bowel grafting is indicated only in case of life-threatening progressive cirrhogenic liver disease.",
author = "Olivier Goulet and Jan, {Dominique M.} and Nicole Brousse and Danielle Canioni and Sabine Sarnacki and Claude Ricour and Yann R{\'e}villon",
year = "1997",
month = "3",
language = "French",
volume = "13",
pages = "323--334",
journal = "Medecine/Sciences",
issn = "0767-0974",
publisher = "Editions EDK",
number = "3",

}

TY - JOUR

T1 - La transplantation intestinale

AU - Goulet, Olivier

AU - Jan, Dominique M.

AU - Brousse, Nicole

AU - Canioni, Danielle

AU - Sarnacki, Sabine

AU - Ricour, Claude

AU - Révillon, Yann

PY - 1997/3

Y1 - 1997/3

N2 - The management of patients with intestinal failure has benefited from progress in parenteral nutrition (PN), especially home-based PN. Intestinal transplantation is henceforth possible and appears now, under certain conditions, the logical therapeutic option. Since 1985, more than 180 small-bowel grafts have been performed, involving the isolated small bowel with or without the colon (38%), the liver plus the small bowel (46%) or several more organs (16%). Two thirds of the recipients were under 20 years of age, and indications were short-bowel syndrome (64%), severe intractable diarrhea (13%), abdominal cancer (13%) or chronic intestinal pseudo-obstruction syndrome (8%). Fifty one per cent of the patients survived more than two years after graft. Patient and graft survival depend on the type of immunosuppression, i.e. CyA or FK506. The results must be carefully interpreted as they represent the first experience in numerous centers using different immunosuppression protocols, without any randomization. Results obtained in the largest of these centers are more indicative of the current situation. This article reviews the main aspects of human intestinal transplantation with special focus on graft rejection in terms of immunohistochemical expression which is decisive for diagnosis and specific treatment. Functional grafts lead to gastrointestinal autonomy (weaning of PN) while maintaining satisfactory nutritional status and normal growth in childhood. Intestinal transplantation is theoretically indicated for all patients permanently or lengthily dependent on PN. However, as PN is generally well tolerated, even for long periods, each indication of transplantation must be carefully weighed up in terms of iatrogenic risk and quality of life. When PN has reached its limits, especially those associated with vascular, infectious, hepatic or metabolic complications, intestinal transplantation must be considered. Transplantation of the small bowel alone remains the first option, as combined liver-small bowel grafting is indicated only in case of life-threatening progressive cirrhogenic liver disease.

AB - The management of patients with intestinal failure has benefited from progress in parenteral nutrition (PN), especially home-based PN. Intestinal transplantation is henceforth possible and appears now, under certain conditions, the logical therapeutic option. Since 1985, more than 180 small-bowel grafts have been performed, involving the isolated small bowel with or without the colon (38%), the liver plus the small bowel (46%) or several more organs (16%). Two thirds of the recipients were under 20 years of age, and indications were short-bowel syndrome (64%), severe intractable diarrhea (13%), abdominal cancer (13%) or chronic intestinal pseudo-obstruction syndrome (8%). Fifty one per cent of the patients survived more than two years after graft. Patient and graft survival depend on the type of immunosuppression, i.e. CyA or FK506. The results must be carefully interpreted as they represent the first experience in numerous centers using different immunosuppression protocols, without any randomization. Results obtained in the largest of these centers are more indicative of the current situation. This article reviews the main aspects of human intestinal transplantation with special focus on graft rejection in terms of immunohistochemical expression which is decisive for diagnosis and specific treatment. Functional grafts lead to gastrointestinal autonomy (weaning of PN) while maintaining satisfactory nutritional status and normal growth in childhood. Intestinal transplantation is theoretically indicated for all patients permanently or lengthily dependent on PN. However, as PN is generally well tolerated, even for long periods, each indication of transplantation must be carefully weighed up in terms of iatrogenic risk and quality of life. When PN has reached its limits, especially those associated with vascular, infectious, hepatic or metabolic complications, intestinal transplantation must be considered. Transplantation of the small bowel alone remains the first option, as combined liver-small bowel grafting is indicated only in case of life-threatening progressive cirrhogenic liver disease.

UR - http://www.scopus.com/inward/record.url?scp=0030940425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030940425&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 323

EP - 334

JO - Medecine/Sciences

JF - Medecine/Sciences

SN - 0767-0974

IS - 3

ER -